If you liked this article you might like

Cramer's 'Mad Money' Recap: Now, the Focus Is Earnings
Investors Shun Bed Bath & Beyond, Walgreens Growth Deals
Bed Bath & Beyond Deal Shows Right Kind of Risk Taking